Articles
Accommodative IOL Finding Its Niche
It's proving to be a solid option for refractive lens exchange and non-Medicare cataract patients, including presbyopes.
By JOSEPH HOFFMAN
at press time - Oxigene Sees Promise in Wet AMD Drug
A Success Spurs Company to Expand R&D.
contact lens business - Coming Attractions
Remarkable new contact lenses are on the horizon.
By Christopher Kent, Senior
guest editorial - How Costs Affect Reimbursement
Avoiding new technology is bad for reimbursement.
By Brette McClellan
Issues in Custom LASIK: Return on Investment
Practices using the new technology provide a status report.
By Rochelle Nataloni, contributing writer
Malpractice Insurance Mess: Is The Worst Over?
It doesn't feel that way to ophthalmologists crunched by high premiums, but some signs point to relief.
By Jerry Helzner, contributing editor
marketplace
Focus on Phacoemulsification Systems
Maximizing Efficiency in Your ASC
Doing so brings cost savings and reduces error.
By VICKEY HAWKINS, COA, AND
New Frontiers in Glaucoma Surgery
We now have several strategies to compare with trabeculectomy.
By HEATHER A. NESTI, M.D., HERBERTO
on the net
Sites help introduce the Crystalens
Reimbursement Status for New Products
You can file claims when you use many of these next-generation technologies.
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO
research digest
Results of recent research into glaucoma medications.
rx perspective - Re-Evaluating Beta-Blocker Safety
A review of recent studies shows that many concerns are unwarranted.
By Paul J. Lama, M.D.
spotlight on technology and technique - How Important is Custom Ablation?
A newly approved laser produces results as good as wavefront-guided -- without individual wavefront data.
By Christopher Kent, Senior
stat tracker
The Latest Data on IOL Use
Taking a Custom Approach to Dry Eye Treatment
In this practice, using all options in varying combinations proves to be the best strategy.
By JONATHAN R. PIRNAZAR, M.D.
viewpoint
After Reform, Are We Out of Allies?
Allergan Education Forum: Effective Anti-infective Measures Optimize Surgical Outcomes
Surgeons discuss their individual strategies.
The IntraLase Advantage
A study found that visual outcomes of IntraLase-treated eyes at 1-day post-op surpassed those of eyes treated with the Hansatome microkeratome.